OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages
Muhammad Ovais, Mengyu Guo, Chunying Chen
Advanced Materials (2019) Vol. 31, Iss. 19
Closed Access | Times Cited: 264

Showing 1-25 of 264 citing articles:

The role of macrophages in the resolution of inflammation
Satoshi Watanabe, Michael Alexander, Alexander V. Misharin, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 7, pp. 2619-2628
Open Access | Times Cited: 694

Harnessing tumor-associated macrophages as aids for cancer immunotherapy
Xiaolei Li, Rui Liu, Xiao Su, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 291

Tailoring Materials for Modulation of Macrophage Fate
Jinhua Li, Xinquan Jiang, Hongjun Li, et al.
Advanced Materials (2021) Vol. 33, Iss. 12
Open Access | Times Cited: 282

Artificial Enzyme Catalyzed Cascade Reactions: Antitumor Immunotherapy Reinforced by NIR‐II Light
Mei Wen, Jiang Ouyang, Chuan‐Wan Wei, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 48, pp. 17425-17432
Closed Access | Times Cited: 241

Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Nisha Kumari, Seung Hong Choi
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 214

CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling
Renlun Huang, Shengqi Wang, Neng Wang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 213

Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Lang Rao, Shukun Zhao, Churan Wen, et al.
Advanced Materials (2020) Vol. 32, Iss. 47
Open Access | Times Cited: 206

Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
Guorong Hu, Mengfei Guo, Juanjuan Xu, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 195

Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases
Wei He, Neha Kapate, C. Wyatt Shields, et al.
Advanced Drug Delivery Reviews (2019) Vol. 165-166, pp. 15-40
Open Access | Times Cited: 195

Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment
Shan Gao, Xiaoye Yang, Jiangkang Xu, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12567-12603
Closed Access | Times Cited: 177

Designing Stimuli‐Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment
Muhammad Ovais, Sudip Mukherjee, A. Pramanik, et al.
Advanced Materials (2020) Vol. 32, Iss. 22
Closed Access | Times Cited: 166

Progress on Modulating Tumor‐Associated Macrophages with Biomaterials
Meilyn Sylvestre, Courtney A. Crane, Suzie H. Pun
Advanced Materials (2019) Vol. 32, Iss. 13
Open Access | Times Cited: 162

Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
Pengcheng Zhang, Yi­hui Zhai, Ying Cai, et al.
Advanced Materials (2019) Vol. 31, Iss. 49
Closed Access | Times Cited: 148

Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 147

Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy
Yang Zhou, Xianchun Chen, Jun Cao, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 31, pp. 6765-6781
Closed Access | Times Cited: 143

Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis
Zerong Pei, Shuting Chen, Liqin Ding, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 211-241
Closed Access | Times Cited: 131

Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Yanhui Zheng, Yaobao Han, Qiao Sun, et al.
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 116

Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy
Jing Huang, Bin Yang, Yuan Peng, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 21
Open Access | Times Cited: 115

Smart transformable nanoparticles for enhanced tumor theranostics
Jinjin Chen, Zhongyu Jiang, Yu Shrike Zhang, et al.
Applied Physics Reviews (2021) Vol. 8, Iss. 4
Closed Access | Times Cited: 110

Hybrid‐Membrane‐Decorated Prussian Blue for Effective Cancer Immunotherapy via Tumor‐Associated Macrophages Polarization and Hypoxia Relief
Lin Hou, Xuan Gong, Jing Yang, et al.
Advanced Materials (2022) Vol. 34, Iss. 14
Closed Access | Times Cited: 101

Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice
Yudong Song, Luke F. Bugada, Ruiting Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 643
Open Access | Times Cited: 73

Emerging ultrasmall luminescent nanoprobes for in vivo bioimaging
Shihua Li, Jing Wei, Qiaofeng Yao, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 5, pp. 1672-1696
Open Access | Times Cited: 64

Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2023) Vol. 574, pp. 216397-216397
Open Access | Times Cited: 60

Page 1 - Next Page

Scroll to top